DSpace at RU >

Browsing by Author Schuuring, E.

Full Text	Issue Date	Title	Author(s)
	2010	CD44 expression predicts local recurrence after radiotherapy in larynx cancer.	Jong, M.C.J. de; Pramana, J.; Wal, J.E. van der, et al
	2012	Clonality analysis in lymphoproliferative disease using the BIOMED-2 multiplex PCR protocols: experience from the EuroClonality group EQA scheme	Harris, S.; Bruggemann, M.; Groenen, P.J., et al
	2011	EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.	Thunnissen, E.; Bovee, J.V.; Bruinsma, H., et al
	2012	EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations	Langerak, A.W.; Groenen, P.J.T.A.; Bruggemann, M., et al
	1997	Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint	Sinke, R.J.; Dijkhuizen, T.; Janssen, H.A.P., et al
	2009	Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity.	Schraders, M.; Oeschger, S.; Kluin, P.M., et al
	2007	Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936.	Krieken, J.H.J.M. van; Langerak, A.W.; Macintyre, E.A., et al
	2009	Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.	Broek, G.B. van den; Wildeman, M.; Rasch, C.R., et al
	2007	Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936.	Langerak, A.W.; Molina, T.J.; Lavender, F.L., et al
	2004	Quality control in diagnostic molecular pathology in the Netherlands; proficiency testing for patient identification in tissue samples.	Thunnissen, F.B.J.M.; Tilanus, M.G.J.; Ligtenberg, M.J.L., et al
	2005	Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients.	Guikema, J.; Rosati, S.; Akkermans, K., et al
	2009	Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?	Wildeman, M.A.; Gibcus, J.H.; Hauptmann, M., et al
	2007	Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.	Evans, P.A.; Pott, C.; Groenen, P.J.T.A., et al
	2006	t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.	Fenton, J.A.; Schuuring, E.; Barrans, S.L., et al
	2006	Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.	Rossum, A.G. van; Bragt, M.P. van; Schuuring-Scholtes, E., et al
	2012	Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma	van Hooff, S.R.; Leusink, F.K.; Roepman, P., et al